​

Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TDOC Stock Forecast

Teladoc Health (TDOC) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $13.00 and a low of $9.00. This represents a 61.05% increase from the last price of $6.83.

$5 $9 $13 $17 $21 $25 High: $13 Avg: $11 Low: $9 Last Closed Price: $6.83

TDOC Stock Rating

Teladoc Health stock's rating consensus is Hold, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (38.89%), 22 Hold (61.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 36 22 14 0 Strong Sell Sell Hold Buy Strong Buy

TDOC Price Target Upside V Benchmarks

TypeNameUpside
StockTeladoc Health61.05%
SectorHealthcare Stocks 35.25%
IndustryHealthcare Information Services Stocks 36.10%

Price Target Trends

1M3M12M
# Anlaysts--7
Avg Price Target--$12.43
Last Closing Price$6.83$6.83$6.83
Upside/Downside--81.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 252319--24
Mar, 253319--25
Feb, 253319--25
Jan, 253319--25
Dec, 244319--26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 04, 2024Jessica TassanPiper Sandler$13.00$11.0118.07%90.34%
Oct 31, 2024Daniel GrosslightCitigroup$11.00$8.8624.15%61.05%
Oct 30, 2024Elizabeth AndersonEvercore ISI$9.00$8.861.58%31.77%
Aug 06, 2024Jessica TassanPiper Sandler$10.00$7.6031.58%46.41%
Jun 11, 2024Steve ValiquetteBarclays$20.00$10.4990.66%192.83%
May 31, 2024Glen SantangeloJefferies$10.00$11.29-11.43%46.41%
May 20, 2024Glen SantangeloJefferies$14.00$12.3912.99%104.98%
Apr 05, 2024George HillDeutsche Bank$18.00$14.6522.87%163.54%
Apr 12, 2023Jeff GarroStephens$25.00$25.86-3.33%266.03%
Dec 13, 2022Citigroup$33.00$27.6319.44%383.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 04, 2024Piper SandlerOverweightOverweighthold
Oct 31, 2024Cowen & Co.HoldHoldhold
Oct 31, 2024BarclaysOverweightOverweighthold
Oct 31, 2024CitigroupNeutralNeutralhold
Oct 09, 2024RBC CapitalOutperformOutperformhold
Oct 08, 2024RBC CapitalBuyBuyhold
Oct 08, 2024Evercore ISIOutperformOutperformhold
Sep 17, 2024RBC CapitalBuyBuyhold
Sep 17, 2024JefferiesBuyBuyhold
Sep 17, 2024JefferiesHoldHoldhold

Financial Forecast

EPS Forecast

$-85 $-67 $-49 $-31 $-13 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.36$-2.73$-84.60$-1.36$-5.87----
Avg Forecast$-1.37$-3.25$-61.26$-1.38$-5.82$-0.89$-0.80$-0.63$-0.03
High Forecast$-1.28$-3.04$-58.91$-0.99$-5.64$-0.50$-0.08$0.47$-0.02
Low Forecast$-1.44$-3.42$-63.04$-1.45$-5.94$-1.23$-1.20$-1.11$-0.03
Surprise %291.24%-16.00%38.10%-1.45%0.86%----

Revenue Forecast

$1B $1B $2B $2B $3B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.09B$2.03B$2.41B$2.60B$2.57B----
Avg Forecast$1.09B$2.03B$2.40B$2.61B$2.57B$2.55B$2.59B$2.66B$2.75B
High Forecast$1.13B$2.11B$2.46B$2.62B$2.60B$2.61B$2.59B$2.66B$2.82B
Low Forecast$1.03B$1.92B$2.33B$2.51B$2.55B$2.41B$2.58B$2.66B$2.64B
Surprise %0.41%0.35%0.18%-0.39%0.04%----

Net Income Forecast

$-550B $-430B $-310B $-190B $-70B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-485.14M$-428.79M$-13.66B$-220.37M$-1.00B----
Avg Forecast$-3.89B$-385.89M$-434.22B$-220.37M$-953.23M$-156.71M$-148.59M$-92.16M$-4.11M
High Forecast$-3.11B$-308.71M$-347.37B$-176.29M$-928.45M$-81.96M$-12.97M$77.75M$-3.90M
Low Forecast$-4.67B$-463.07M$-521.06B$-264.44M$-978.01M$-201.87M$-197.67M$-182.81M$-4.24M
Surprise %-87.53%11.12%-96.85%-5.04%----

TDOC Forecast FAQ

Is Teladoc Health stock a buy?

Teladoc Health stock has a consensus rating of Hold, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 22 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Teladoc Health is a neutral investment for most analysts.

What is Teladoc Health's price target?

Teladoc Health's price target, set by 36 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $9 at the low end to $13 at the high end, suggesting a potential 61.05% change from the previous closing price of $6.83.

How does Teladoc Health stock forecast compare to its benchmarks?

Teladoc Health's stock forecast shows a 61.05% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the healthcare information services stocks industry (36.10%).

What is the breakdown of analyst ratings for Teladoc Health over the past three months?

  • April 2025: 8.33% Strong Buy, 12.50% Buy, 79.17% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 12.00% Strong Buy, 12.00% Buy, 76.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 12.00% Strong Buy, 12.00% Buy, 76.00% Hold, 0% Sell, 0% Strong Sell.

What is Teladoc Health’s EPS forecast?

Teladoc Health's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.89, marking a -84.84% decrease from the reported $-5.87 in 2024. Estimates for the following years are $-0.8 in 2026, $-0.63 in 2027, and $-0.03 in 2028.

What is Teladoc Health’s revenue forecast?

Teladoc Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.55B, reflecting a -0.94% decrease from the reported $2.57B in 2024. The forecast for 2026 is $2.59B, followed by $2.66B for 2027, and $2.75B for 2028.

What is Teladoc Health’s net income forecast?

Teladoc Health's net income forecast for the fiscal year ending in December 2025 stands at $-157M, representing a -84.35% decrease from the reported $-1.001B in 2024. Projections indicate $-149M in 2026, $-92.161M in 2027, and $-4.114M in 2028.